FDA Adverse Event
Injury
Summary report: N
TESTOSTERONE TEST
MDR report key: 20182661
·
Received September 9, 2024
Report
- Report Number
- MW5159386
- Event Type
- Injury
- Date Received
- September 9, 2024
- Date of Event
- June 10, 2024
- Report Date
- September 5, 2024
- Manufacturer
- EVERLYWELL DIAGNOSTICS/ EVERLYWELL, INC.
- Product Code
- CDZ
- Product Problem
- Yes
- Report Source
- Voluntary report
- Reporter Occupation
- PATIENT
- Health Professional
- *
Narratives
Description of Event or Problem · 0
EVERLYWELL TESTOSTERONE TEST KITS (2 PERFORMED) ARE EXTREMELY INACCURATE WHEN COMPARED TO VENOUS LAB TESTING. INITIALLY ADJUSTED EXOGENOUS HORMONE SUPPLEMENTATION BASED ON RESULTS, AT A DETRIMENT TO PERSONAL HEALTH. AFTER REALIZING LAB TESTS WERE INACCURATE, CONFIRMED TRUE LEVELS WITH MEDICAL LABORATORY VENOUS DRAW AND WAS ABLE TO AVOID PERMANENT MEDICAL ISSUES. NONE OF THE TEST KITS FROM EVERLYWELL WERE ACCURATE. REF REPORT: MW5159385.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1588638 | TESTOSTERONE TEST | RADIOIMMUNOASSAY, TESTOSTERONES AND DIHYDROTESTOSTERONE | CDZ | EVERLYWELL DIAGNOSTICS/ EVERLYWELL, INC. |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 34 YR | Male | Required Intervention | ALBUTEROL| ALLEGRA| BERBERINE| FLONASE| METFORMIN |